tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HROW Stock Latest News

Harrow Health’s Strategic Acquisition and Market Positioning Justify Buy Rating
RatingsHarrow Health’s Strategic Acquisition and Market Positioning Justify Buy Rating
22d ago
HROW
Harrow enters commercialization agreement with Samsung Bioepis for biosimilars
PremiumThe Fly
Harrow enters commercialization agreement with Samsung Bioepis for biosimilars
23d ago
HROW
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
28d ago
AMC
BYD
Video: Capricor plunges after CRL, Performance Foods up after seeing interest
PremiumThe Fly
Video: Capricor plunges after CRL, Performance Foods up after seeing interest
29d ago
VFC
CAPR
Harrow initiated with an Overweight at Cantor Fitzgerald amid path to growth
PremiumThe Fly
Harrow initiated with an Overweight at Cantor Fitzgerald amid path to growth
29d ago
HROW
Harrow initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyHarrow initiated with an Overweight at Cantor Fitzgerald
29d ago
HROW
Harrow Health Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Harrow Health Approves Key Proposals at Annual Meeting
2M ago
8K
HROW
Harrow management to meet virtually with Lake Street
Premium
The Fly
Harrow management to meet virtually with Lake Street
2M ago
HROW
Harrow initiated with a Buy at BTIG
PremiumThe Fly
Harrow initiated with a Buy at BTIG
2M ago
HROW
Harrow Health’s Strategic Expansion and Growth Potential in Branded Pharmaceuticals
PremiumRatings
Harrow Health’s Strategic Expansion and Growth Potential in Branded Pharmaceuticals
2M ago
HROW
Harrow initiated with an Outperform at William Blair
PremiumThe Fly
Harrow initiated with an Outperform at William Blair
2M ago
HROW
Harrow acquires U.S. commercial rights to BYQLOVI 0.05% from Formosa
PremiumThe Fly
Harrow acquires U.S. commercial rights to BYQLOVI 0.05% from Formosa
2M ago
HROW
Harrow acquires commercial rights for Byqlovi 0.05%
PremiumThe FlyHarrow acquires commercial rights for Byqlovi 0.05%
2M ago
HROW
Harrow Health’s Earnings Call: Strong Growth Amid Challenges
Premium
Company Announcements
Harrow Health’s Earnings Call: Strong Growth Amid Challenges
3M ago
HROW
Harrow price target lowered to $54 from $58 at Craig-Hallum
Premium
The Fly
Harrow price target lowered to $54 from $58 at Craig-Hallum
3M ago
HROW
Harrow price target raised to $60 from $57 at H.C. Wainwright
PremiumThe Fly
Harrow price target raised to $60 from $57 at H.C. Wainwright
3M ago
HROW
Harrow Health Reports Strong Q1 2025 Revenue Growth
PremiumCompany Announcements
Harrow Health Reports Strong Q1 2025 Revenue Growth
3M ago
HROW
Harrow reports Q1 EPS (38c) vs. (28c) last year
PremiumThe Fly
Harrow reports Q1 EPS (38c) vs. (28c) last year
3M ago
HROW
Harrow confident in 2025 revenue target $280M, consensus $283.19M
PremiumThe Fly
Harrow confident in 2025 revenue target $280M, consensus $283.19M
3M ago
HROW
Harrow expands Vevye Access for All program
PremiumThe FlyHarrow expands Vevye Access for All program
4M ago
HROW
Harrow price target lowered to $65 from $69 at B. Riley
Premium
The Fly
Harrow price target lowered to $65 from $69 at B. Riley
4M ago
HROW
Harrow Health’s Strong Financial Performance and Growth Prospects Justify Buy Rating and $57 Price Target
Premium
Ratings
Harrow Health’s Strong Financial Performance and Growth Prospects Justify Buy Rating and $57 Price Target
4M ago
HROW

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >